2025 HCPCS code J9000

Injection, doxorubicin hydrochloride, 10 mg

Use J9000 to report only the drug itself. Administration of the drug may be reported separately using the appropriate CPT or HCPCS code depending on the payer and setting. Refer to current HCPCS and CPT coding guidelines.

Modifiers may be applicable in certain situations (e.g., JW - Drug amount discarded/not administered to any patient). Refer to current modifier guidelines.

Medical necessity for doxorubicin hydrochloride must be supported by documentation that shows the drug is reasonable and necessary for the individual patient's cancer treatment based on their specific diagnosis, stage of cancer, and treatment plan.

The physician is responsible for the proper selection, dosage, and administration of the drug. This includes verifying the patient's diagnosis, considering any contraindications or potential drug interactions, ensuring proper intravenous access, monitoring the patient for adverse reactions during administration, and providing appropriate post-administration care.

In simple words: This code covers the chemotherapy drug doxorubicin hydrochloride, given by injection, which is used to treat some cancers.Each unit of this code equals 10 milligrams of the drug.

Doxorubicin hydrochloride is an antineoplastic chemotherapy agent used to treat various types of cancer. This code represents 10 mg of doxorubicin hydrochloride administered via injection (intravenous).

Example 1: A patient with breast cancer receives 10 mg of doxorubicin hydrochloride intravenously as part of their chemotherapy regimen., A patient with ovarian cancer receives 20 mg of doxorubicin hydrochloride (2 units of J9000) intravenously., A patient with leukemia receives 30 mg of doxorubicin hydrochloride (3 units of J9000) intravenously.

Documentation should include the patient's diagnosis, the dose of doxorubicin hydrochloride administered, the route of administration (intravenous), the date and time of administration, and any adverse reactions observed. Medical necessity for the chemotherapy treatment should be clearly documented.

** Brand names for doxorubicin hydrochloride include Adriamycin, Rubex. Check with individual payers for specific coverage policies and reimbursement rates.

  • Payment Status: Active
  • Specialties:Oncology, Hematology
  • Place of Service:Office, Inpatient Hospital, Outpatient Hospital, Clinic, Ambulatory Surgical Center
** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.